GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Astrana Health Inc (NAS:ASTH) » Definitions » EV-to-EBIT

Astrana Health (Astrana Health) EV-to-EBIT

: 15.93 (As of Today)
View and export this data going back to 2015. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Astrana Health's Enterprise Value is $1,687 Mil. Astrana Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $106 Mil. Therefore, Astrana Health's EV-to-EBIT for today is 15.93.

The historical rank and industry rank for Astrana Health's EV-to-EBIT or its related term are showing as below:

ASTH' s EV-to-EBIT Range Over the Past 10 Years
Min: -2038.19   Med: 5.82   Max: 347.11
Current: 15.93

During the past 13 years, the highest EV-to-EBIT of Astrana Health was 347.11. The lowest was -2038.19. And the median was 5.82.

ASTH's EV-to-EBIT is ranked better than
55.61% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.24 vs ASTH: 15.93

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Astrana Health's Enterprise Value for the quarter that ended in Dec. 2023 was $1,615 Mil. Astrana Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $106 Mil. Astrana Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 6.56%.


Astrana Health EV-to-EBIT Historical Data

The historical data trend for Astrana Health's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astrana Health Annual Data
Trend Jan14 Mar15 Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.37 77.73 39.17 14.07 15.25

Astrana Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.07 16.99 12.41 12.59 15.25

Competitive Comparison

For the Medical Care Facilities subindustry, Astrana Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astrana Health EV-to-EBIT Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Astrana Health's EV-to-EBIT falls into.



Astrana Health EV-to-EBIT Calculation

Astrana Health's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1687.342/105.941
=15.93

Astrana Health's current Enterprise Value is $1,687 Mil.
Astrana Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $106 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Astrana Health  (NAS:ASTH) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Astrana Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=105.941/1615.37271
=6.56 %

Astrana Health's Enterprise Value for the quarter that ended in Dec. 2023 was $1,615 Mil.
Astrana Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $106 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Astrana Health EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Astrana Health's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Astrana Health (Astrana Health) Business Description

Traded in Other Exchanges
Address
1668 S. Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Apollo Medical Holdings Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care in a cost-effective manner. It is focused on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.
Executives
Chandan Basho officer: See Remarks 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
John Vong officer: SVP-Chief Accounting Officer 4288 BIRCHWOOD AVENUE, SEAL BEACH CA 90740
Linda Marsh director 100 N. STONEMAN AVE., ROOM 200, ALHAMBRA CA 91801
Allied Physicians Of California, A Profession Medical Corp 10 percent owner 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Weili Dai, director 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
J. Lorraine Estradas director 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
David Schmidt director 700 N. BRAND BLVD, SUITE 220, GLENDALE CA 91203
Albert Waichow Young officer: Chief Administrative Officer 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Adrian Vazquez officer: Chief Medical Officer C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Thomas S. Lam director, officer: President and Co-CEO 1668 GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Kenneth T. Sim director, officer: Executive Chairman and Co-CEO 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Brandon Sim director, officer: See Remarks C/O APOLLO MEDICAL HOLDINGS, INC., 1668 S. GARFIELD AVENUE, 3RD FLOOR, ALHAMBRA CA 91801
Eric Chin officer: Chief Financial Officer 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Michael F. Eng director 712 BATAAN PLACE, MONTEREY PARK CA 91755
Hing Ang officer: Chief Operating Officer 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801